Amy Ouderkirk

Amy Ouderkirk, M.S. is an experienced professional in analytical development and quality assurance within the pharmaceutical industry. Currently serving as the Director of Analytical Development at Viridian Therapeutics, Inc. since March 2022, Amy has held various roles, including Associate Director of Analytical Chemistry at the same company and Manager of Analytical Sciences at Alexion Pharmaceuticals, Inc. from August 2020 to March 2022. Responsibilities include overseeing analytical method development, validation, and transfer, along with managing testing conducted by contract organizations for clinical programs. Amy's career includes positions such as Regulatory Affairs Specialist at BioSpherix Medical and Senior Scientist I- CMC Analytical Lead at Bristol-Myers Squibb. Academic qualifications encompass a Master’s degree in Biology from the University of Saint Joseph and a Bachelor of Science in Health Science from the State University of New York Cortland.